NSE filing, NSE: LEMERITE. Summary written from the filing by ALFA Finder's alert engine.
Le Merite Exports Ltd: key numbers
- Share price
- ₹24.40
- Market cap
- ₹305.4 Cr
- Revenue (annual)
- ₹357.5 Cr
- Net profit (annual)
- ₹11.60 Cr
- P/E (TTM)
- -663.0×Sector 48.2×
- Promoter holding
- 59.65%+0.00% QoQ
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Le Merite Exports Ltd
All →Le Merite Exports Other Announcement
Le Merite Exports reported no deviation in the use of preferential issue proceeds for the quarter ended September 30, 2026. Some warrant-linked funds remain pending receipt.
Le Merite Exports Q2 FY27 Results: Net Profit ₹0.9 Cr, Down 79.5% YoY
Le Merite Exports Ltd reported revenue from operations of ₹108.9 Cr (+10.9% YoY) and net profit of ₹0.9 Cr (-79.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.9 Cr · -79.5% YoY
Le Merite Exports Board Meeting Date
Le Merite Exports will hold a board meeting on 05-Nov-2026 to consider unaudited quarterly results for September 2026. The trading window stays closed from 01-Oct-2026 until 07-Nov-2026.
Le Merite Exports Annual General Meeting
Le Merite Exports Limited held its 23rd Annual General Meeting on September 30, 2026, where members considered and approved various ordinary and special business resolutions.
Le Merite Exports Annual General Meeting
Le Merite Exports Limited has issued a notice for its 23rd Annual General Meeting scheduled for September 30, 2026. The agenda includes re-appointments of directors.
Le Merite Exports Management Change
Le Merite Exports re-appointed several executive and independent directors, and appointed a new internal auditor. These management changes were approved during the recent board meeting.
Other business update announcements
All →Suven Life Sciences Business Update
Suven Life Sciences will present seven posters on its CNS pipeline at Neuroscience 2026, Washington DC. Presentations span Phase-3 and preclinical candidates targeting neurodegenerative and neuropsychiatric disorders.
Smruthi Organics Business Update
Smruthi Organics received the Brazilian GMP (CBPF) certificate for its Unit II API, Levamlodipine Besylate Hemi pentahydrate. This strengthens its regulatory presence in the Brazilian pharmaceutical market.
Kreon Finnancial Services Business Update
Kreon Financial Services launched StuCred for Startups, a mentorship initiative for student entrepreneurs. No revenue projection or monetary value is attached to the new program.
Aurobindo Pharma Business Update
Aurobindo Pharma disclosed that US FDA classified its Lannett facility inspection as Official Action Indicated (OAI). The company states there is no quantifiable financial or operational impact.
Gokaldas Exports Business Update
Gokaldas Exports issued a press release clarifying a customer's Chapter 11 filing, which involves USD 4.11 million of receivables held by its African subsidiary Atraco. It also reports two new customers onboarded in its African operations.
Adani Enterprises Business Update
Adani Enterprises' Kutch Copper became the first Indian producer to receive the Copper Mark certification. It recognises responsible copper production under independent ESG audits.